Evidence map›Paper›PMID 42018069›Full record

ArticleCanadian journal of public health = Revue canadienne de sante publique2026

A profile of heart failure in the James and Hudson's Bay region of Ontario: A retrospective cohort study.

Sabastian M B Koprich, Samuel J Petrie, Robert P Gagnon, Douglas S Lee, Sandra J Kioke, Heather J Ross, Beth S Rachlis, Anne M Simard

Abstract read
PubMed Publisher
In one paragraph

Article in Canadian journal of public health = Revue canadienne de sante publique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sabastian M B KoprichICES Central, Toronto, ON, Canada.
Samuel J PetrieDivision of Cardiology, Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.
Robert P GagnonWeeneebayko Area Health Authority (WAHA), Moose Factory, ON, Canada.
Douglas S LeeICES Central, Toronto, ON, Canada.
Sandra J KiokeWeeneebayko Area Health Authority (WAHA), Moose Factory, ON, Canada.
Heather J RossDivision of Cardiology, Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.
Beth S RachlisICES Central, Toronto, ON, Canada.
Anne M SimardDivision of Cardiology, Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, ON, Canada. Anne.simard@uhn.ca.ORCID http://orcid.org/0009-0002-7977-9311

Funding

Ontario Ministry of Health and Long-Term Care Annual operational grantUniversity of Toronto TRANSFORM HF Master's award
6 · The paper itself

Abstract

objectivesThe James and Hudson Bay (JHB) region in Northern Ontario is home to an estimated 12,000 people; the majority are Mushkegowuk Cree. To better respond to cardiovascular needs in the region and leverage existing partnerships between the Weeneebayko Area Health Authority's Minomathowin Department, ICES, and University Health Network, this study aimed to profile confirmed and possible heart failure (HF) prevalence among community members.

methodsA retrospective cohort design, using administrative databases housed at ICES, identified community members with possible and confirmed HF as of March 31, 2023. The eligible population included individuals alive, < 105 years of age, and living in the JHB, based on postal code. Confirmed HF cases were identified from the ICES-derived Congestive Heart Failure cohort. Possible HF was defined as the presence of HF risk factors consistent with Canadian Cardiovascular Society guideline definitions. The use of cardiovascular diagnostic tests, notably natriuretic peptide, was also explored.

resultsOf the 9495 community members who met eligibility criteria, 144 (1.5%) had confirmed HF and 993 (10.5%) met the definition of possible HF. During routine care, the use of HF diagnostic biomarker testing (brain natriuretic peptide) was low in both confirmed (17.4%) and possible HF (5.6%) cohorts when compared to measurement of potassium, hemoglobin, sodium, or creatinine testing.

conclusionThis study identified a significant proportion of possible and confirmed HF cases among community members residing in JHB. The findings underscore a critical need for screening and referral pathways, earlier intervention, and optimization of HF care.

Indexed as

First NationsHeart failurePrevalenceRisk factorsRoutine diagnostic tests

Identifiers

PMID42018069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.